JP2022513806A5 - - Google Patents

Info

Publication number
JP2022513806A5
JP2022513806A5 JP2021533584A JP2021533584A JP2022513806A5 JP 2022513806 A5 JP2022513806 A5 JP 2022513806A5 JP 2021533584 A JP2021533584 A JP 2021533584A JP 2021533584 A JP2021533584 A JP 2021533584A JP 2022513806 A5 JP2022513806 A5 JP 2022513806A5
Authority
JP
Japan
Prior art keywords
referred
sequence
lpp
loop
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021533584A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513806A (ja
Filing date
Publication date
Priority claimed from GBGB1820286.1A external-priority patent/GB201820286D0/en
Priority claimed from GBGB1906534.1A external-priority patent/GB201906534D0/en
Application filed filed Critical
Priority claimed from PCT/GB2019/053540 external-priority patent/WO2020120984A1/en
Publication of JP2022513806A publication Critical patent/JP2022513806A/ja
Publication of JP2022513806A5 publication Critical patent/JP2022513806A5/ja
Priority to JP2024084502A priority Critical patent/JP2024119862A/ja
Pending legal-status Critical Current

Links

JP2021533584A 2018-12-13 2019-12-13 Mt1-mmpに特異的な二環式ペプチドリガンド Pending JP2022513806A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024084502A JP2024119862A (ja) 2018-12-13 2024-05-24 Mt1-mmpに特異的な二環式ペプチドリガンド

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1820286.1 2018-12-13
GBGB1820286.1A GB201820286D0 (en) 2018-12-13 2018-12-13 Bicyclic peptide ligands specific for mt1-mmp
GBGB1906534.1A GB201906534D0 (en) 2019-05-09 2019-05-09 Bicycle peptide ligands specific for MT1-MMP
GB1906534.1 2019-05-09
PCT/GB2019/053540 WO2020120984A1 (en) 2018-12-13 2019-12-13 Bicyclic peptide ligands specific for mt1-mmp

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024084502A Division JP2024119862A (ja) 2018-12-13 2024-05-24 Mt1-mmpに特異的な二環式ペプチドリガンド

Publications (2)

Publication Number Publication Date
JP2022513806A JP2022513806A (ja) 2022-02-09
JP2022513806A5 true JP2022513806A5 (cg-RX-API-DMAC10.html) 2022-12-19

Family

ID=68988066

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021533584A Pending JP2022513806A (ja) 2018-12-13 2019-12-13 Mt1-mmpに特異的な二環式ペプチドリガンド
JP2024084502A Pending JP2024119862A (ja) 2018-12-13 2024-05-24 Mt1-mmpに特異的な二環式ペプチドリガンド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024084502A Pending JP2024119862A (ja) 2018-12-13 2024-05-24 Mt1-mmpに特異的な二環式ペプチドリガンド

Country Status (12)

Country Link
US (1) US20220024982A1 (cg-RX-API-DMAC10.html)
EP (1) EP3894010A1 (cg-RX-API-DMAC10.html)
JP (2) JP2022513806A (cg-RX-API-DMAC10.html)
KR (2) KR20210123295A (cg-RX-API-DMAC10.html)
CN (1) CN113507962A (cg-RX-API-DMAC10.html)
AU (2) AU2019398516B2 (cg-RX-API-DMAC10.html)
BR (1) BR112021011340A2 (cg-RX-API-DMAC10.html)
CA (1) CA3122669A1 (cg-RX-API-DMAC10.html)
IL (2) IL326448A (cg-RX-API-DMAC10.html)
MX (1) MX2021006991A (cg-RX-API-DMAC10.html)
SG (1) SG11202106081YA (cg-RX-API-DMAC10.html)
WO (1) WO2020120984A1 (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ731185A (en) 2014-10-29 2024-03-22 Bicyclerd Ltd Bicyclic peptide ligands specific for mt1-mmp
EP3559018A1 (en) 2016-12-23 2019-10-30 Bicyclerd Limited Peptide derivatives having novel linkage structures
WO2019002842A1 (en) 2017-06-26 2019-01-03 Bicyclerd Limited BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF
JP7670481B2 (ja) 2017-08-04 2025-04-30 バイスクルテクス・リミテッド Cd137に対して特異的な二環式ペプチドリガンド
TWI825046B (zh) 2017-12-19 2023-12-11 英商拜西可泰克斯有限公司 Epha2特用之雙環胜肽配位基
CA3091775A1 (en) 2018-02-23 2019-08-29 Bicycletx Limited Multimeric bicyclic peptide ligands
US11180531B2 (en) 2018-06-22 2021-11-23 Bicycletx Limited Bicyclic peptide ligands specific for Nectin-4
GB201820288D0 (en) * 2018-12-13 2019-01-30 Bicycle Tx Ltd Bicycle peptide ligaands specific for MT1-MMP
GB201820295D0 (en) * 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for MT1-MMP
GB201820325D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for psma
WO2020128527A1 (en) 2018-12-21 2020-06-25 Bicyclerd Limited Bicyclic peptide ligands specific for pd-l1
EP3897849A1 (en) 2018-12-21 2021-10-27 BicycleTx Limited Bicyclic peptide ligands specific for pd-l1
GB201900529D0 (en) 2019-01-15 2019-03-06 Bicycletx Ltd Bicyclic peptide ligands specific for CD38
TWI860386B (zh) 2019-07-30 2024-11-01 英商拜西可泰克斯有限公司 異質雙環肽複合物
CN116348476A (zh) 2020-08-03 2023-06-27 拜斯科技术开发有限公司 基于肽的接头
CA3206529A1 (en) * 2021-01-08 2022-07-14 Bicycletx Limited Heterotandem bicyclic peptide complexes
US12539335B2 (en) 2021-09-29 2026-02-03 Conjustar (Zhuhai) Biologics Co., Ltd. Tricyclic polypeptide conjugated drug and use thereof
WO2023088236A1 (zh) * 2021-11-16 2023-05-25 海思科医药集团股份有限公司 Mt1-mmp的双环肽配体及其缀合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
ES2428869T3 (es) 2005-01-24 2013-11-12 Pepscan Systems B.V. Compuestos de unión, compuestos inmunógenos y peptidomiméticos
JP6074574B2 (ja) * 2008-02-05 2017-02-08 バイシクル セラピューティクス リミテッド 方法及び組成物
GB0913775D0 (en) * 2009-08-06 2009-09-16 Medical Res Council Multispecific peptides
WO2013142229A1 (en) * 2012-03-19 2013-09-26 President And Fellows Of Harvard College Designing novel peptides for inducing fibronectin matrix assembly
GB201306623D0 (en) * 2013-04-11 2013-05-29 Bicycle Therapeutics Ltd Modulation of structured polypeptide specificity
NZ731185A (en) * 2014-10-29 2024-03-22 Bicyclerd Ltd Bicyclic peptide ligands specific for mt1-mmp
GB201600911D0 (en) * 2016-01-18 2016-03-02 Bicycle Therapeutics Ltd Stabilized peptide derivatives
GB201607827D0 (en) * 2016-05-04 2016-06-15 Bicycle Therapeutics Ltd Bicyclic peptide-toxin conjugates specific for MT1-MMP
MX2019007367A (es) * 2016-12-23 2020-01-27 Bicycletx Ltd Ligandos de peptido para enlace a mt1-mmp.
GB201713560D0 (en) * 2017-08-23 2017-10-04 Bicycle Therapeutics Ltd Peptide ligands for binding to Mt1-Mmp
ES2985986T3 (es) * 2017-01-06 2024-11-08 Bicyclerd Ltd Conjugado biciclo para tratar el cáncer
EP3615550A1 (en) * 2017-04-27 2020-03-04 BicycleTx Limited Bicyclic peptide ligands and uses thereof

Similar Documents

Publication Publication Date Title
JP2022517399A5 (cg-RX-API-DMAC10.html)
JP2022512478A5 (cg-RX-API-DMAC10.html)
JP2022513223A5 (cg-RX-API-DMAC10.html)
JP2022514255A5 (cg-RX-API-DMAC10.html)
JP2022514687A5 (cg-RX-API-DMAC10.html)
JP2022517442A5 (cg-RX-API-DMAC10.html)
JP2022518695A5 (cg-RX-API-DMAC10.html)
CN1816346B (zh) 耐滥用的苯异丙胺化合物
JP2022517040A5 (cg-RX-API-DMAC10.html)
JP2022542286A5 (cg-RX-API-DMAC10.html)
JP2022514618A5 (cg-RX-API-DMAC10.html)
JP2022544058A5 (cg-RX-API-DMAC10.html)
JP2022518210A5 (cg-RX-API-DMAC10.html)
JP2022517698A5 (cg-RX-API-DMAC10.html)
JP2022552839A5 (cg-RX-API-DMAC10.html)
JP2016501204A5 (cg-RX-API-DMAC10.html)
JP2010518079A5 (cg-RX-API-DMAC10.html)
JP2009533459A (ja) 共有結合する化合物の鎮痛作用の増強と、有害な副作用の減衰と、前記化合物の乱用の予防とのための組成物及び方法
JP2022515720A5 (cg-RX-API-DMAC10.html)
JP2022523972A5 (cg-RX-API-DMAC10.html)
JP2022506716A5 (cg-RX-API-DMAC10.html)
JP2023537921A5 (cg-RX-API-DMAC10.html)
JP2018521977A5 (cg-RX-API-DMAC10.html)
US8080519B2 (en) Compositions and methods for enhanced pharmacological activity of compositions comprising peptide drug substances
KR20210068060A (ko) 주사용 조성물